Journals / Nöropsikiyatri Arşivi / 2012 / Cilt: 49 - Sayı: 3

Akut inmede maliyet değerlendirmesi

Cost evaluation in acute stroke

Pages
172–177
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Whereas diagnostic work-up for etiological determination was considered to increase the cost in neurology ward.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Stroke is a major health problem due to its high mortality and disability rate.
📊
Key Findings & Data:The problem tends to increase in especially rapidly aging populations.
💡
Conclusion & Impact:Whereas diagnostic work-up for etiological determination was considered to increase the cost in neurology ward.
🔬Design:Research Article
📍Scope:2004 Verileri
⚙️Variables:Domain Parameters

Abstract

Objective: Stroke is a major health problem due to its high mortality and disability rate. The problem tends to increase in especially rapidly aging populations. Variations in total cost depend on age, presence of comorbid conditions, several factors influencing the disease severity, and stroke subtypes. Methods: In this study, the costs of diagnostic procedures, treatment, and medical care have been evaluated in 99 hospitalized patients admitted to intensive care unit and neurology clinical wards between April 30th , 2004 and August 13th,2004. Results: The mean length of hospital stay in intensive care unit was 9 days (range: 1-37 days) whereas it was 13 days (range: 2-44 days) in neurology ward. The mean value of total cost was 1,367.29 USD (range: 208.91-7,764.18 USD). Discussion: There was a significant correlation between total cost and length of hospital stay. Total intensive care cost and treatment cost have increased with higher National Institutes of Health Stroke Scale (NIHSS) scores. Whereas diagnostic work-up for etiological determination was considered to increase the cost in neurology ward.

Özet

Amaç: İnme, yüksek mortalite ve dizabilite oranı ile büyük bir sağlık problemi ve yüksek maliyetli bir hastalıktır. Özellikle hızla yaşlanan toplumlarda, yaşla birlikte artan inme sıklığı nedeniyle sorun artmaktadır. Toplam maliyet; yaş, komorbid durumların varlığı, hastalık ciddiyetini gösteren çeşitli faktörler (inme başlangıcındaki nörolojik ve fonksiyonel durum) ve inme alt tipleri ile değişmektedir. Yöntem: Çalışmamızda, 30.04.2004-13.08.2004 tarihleri arasında yoğun bakım ve nöroloji servisine yatan 99 hasta, yatış süreleri içerisinde ve tetkik, tedavi ve bakım maliyetleri karşılaştırmalı olarak değerlendirilmiştir. Bulgular: Yoğun bakımda yatış süresi ortalama 9 (1-37 ) gün, serviste yatış süresi ise ortalama 13 (2-44) gün arasında değişmekte idi. Toplamda tüm ortalama "1,367.29 USD (208.91-7,764.18 USD) TL olduğu saptandı. Sonuç: Yatış süresinin kısalmasının maliyeti anlamlı değerde değiştirdiği, National Institutes of Health Stroke Scale (NIHSS) puanı arttıkça yoğun bakım toplam maliyetinin ve tedavi maliyetinin arttığı görüldü. Servisteki maliyeti artıran en önemli faktör ise etiyolojik araştırma için yapılan laboratuar ve radyolojik tetkiklerdir.

🔖

Cite This Article

KANDEMİR, M., KALYONCU, I. A., BAKAÇ, G., KIRBAŞ, D. (2012). Akut inmede maliyet değerlendirmesi. Nöropsikiyatri Arşivi, Cilt: 49 - Sayı: 3, 172–177. https://ajindex.com/articles/292630

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Caro JJ, Huybrechts KF, Kelly HE. Predicting treatment costs after acute stroke on the basis of patient characteristics at presentation and early dysfunction. Stroke 2001
  2. Evers SM, Struijs JN, Ament AJ, van Genugten ML, Jager JH, van den Bos GA. International comparison of stroke cost studies. Stroke 2004
  3. Teng J, Mayo NE, Latimer E, Hanley J, Wood-Dauphinee S, Côté R, Scott S. Costs and caregiver consequences of early supported discharge for stroke patients. Stroke 2003
  4. Truelsen T, Ekman M, Boysen G: Cost of stroke in Europe. Eur J Neurol 2005
  5. Chang KC, Tseng MC, Weng HH, Lin YH, Liou CW, Tan TY. Prediction of length of stay of first-ever ischemic stroke. Stroke 2002
  6. Claesson L, Gosman-Hedström G, Johannesson M, Fagerberg B, Blomstrand C. Resource utilization and costs of stroke unit care integrated in a care continuum: A 1-year controlled, prospective, randomized study in elderly patients. The Göteborg 70+ Stroke Study. Stroke 2000
  7. Dewey HM, Thrift AG, Mihalopoulos C, Carter R, Macdonell RA, McNeil JJ, Donnan GA. Cost of stroke in Australia from a societal perspective: results from the North East Melbourne Stroke Incidence Study (NEMESİS). Stroke 2001
  8. Diringer MN, Edwards DF, Mattson DT, Akins PT, Sheedy CW, Hsu CY, Dromerick AW. Predictors of acute hospital costs for treatment of ischemic stroke in an academic center. Stroke 1999
  9. Patel A, Knapp M, Perez I, Evans A, Kalra L. Alternative strategies for stroke care: cost-effectiveness and cost-utility analyses from a prospective randomized controlled trial. Stroke 2004a
  10. Caro JJ, Huybrechts KF, Duchesne I: Management patterns and costs of acute ischemic stroke: an international study. For the Stroke Economic Analysis Group. Stroke 2000
  11. Bergman L, van der Meulen JH, Limburg M, Habbema JD. Costs of medical care after first- ever stroke in The Netherlands. Stroke 1995
  12. Jørgensen HS, Nakayama H, Raaschou HO, Olsen TS. Acute stroke care and rehabilitation: An analysis of the direct costs and its clinical and social determinants. The Copenhagen Stroke Study. Stroke 1997
  13. Grieve R, Hutton J, Bhalla A, Rastenytë D, Ryglewicz D, Sarti C, Lamassa M, Giroud M, Dundas R, Wolfe CD. A comparison of the costs and survival of hospital-admitted stroke patients across Europe. Stroke 2001
  14. Yoneda Y, Uehara T,